IGIV 10%

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for IGIV 10%, covering 2012-08-23 to 2020-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: [Phase 2]